Yanping Qu

Dr. Yanping Qu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Medicine
Verified
Journal Article
Open access
YHYang Huaichun
Yang Huaichun
HLHongyu Liu
Hongyu Liu
BHBen Bs Huang
Ben Bs Huang
HZHaodong Bs Zhang
Haodong Bs Zhang
XZXiaoyue Zhu
Xiaoyue Zhu
YQYanping Qu
Yanping Qu
Background: The present study aimed to investigate whether the combination of low-intensity pulsed ultrasound (LIPUS) and aerobic exercise (AE) exerts an enhanced therapeutic benefit for patients with knee osteoarthritis. Methods: Participants were allocated into a LIPUS treatment group, an AE treatment group, and a LIPUS combined with AE (LIPUS + AE) treatment group. Numerical rating scale (NRS) and Lequesne index were determined, and gait analysis was performed before treatment and after 12 weeks of treatment. Results: The LIPUS treatment could significantly alleviate NRS score and Lequesne index in patients with knee osteoarthritis. The AE treatment could significantly alleviate NRS score and Lequesne index, accompanied by improvement in stride length, stride speed, and total walking distance. LIPUS + AE treatment further contributed to an improvement in NRS score and Lequesne index, accompanied by improvement in stride length, stride speed, and total walking distance. At the end of treatment, the Lequesne index improvement on LIPUS + AE treatment group was greater than LIPUS or AE group, NRS score improvement on LIPUS + AE treatment group was greater than LIPUS group. The stride speed, stride length, and total walking distance improvements on LIPUS + AE treatment group were greater than either LIPUS or AE group. Conclusion: The study indicates LIPUS + AE treatment is more effective than LIPUS or AE for knee osteoarthritis. LIPUS + AE promises to be a potential rehabilitation therapy for patients with knee osteoarthritis.

8 October 2026 in Frontiers in Rehabilitation Sciences
Verified
Journal Article
Open access
PDF file
HZHaodong Zhang
Haodong Zhang
JSJie Shen
Jie Shen
YQYanping Qu
Yanping Qu
Background: Spastic paraplegia type 11 (SPG11) is the most common autosomal recessive subtype of hereditary spastic paraplegia, and is characterized by progressive corticospinal tract degeneration, lower-limb spasticity, and gait impairment. Intrathecal baclofen (ITB) effectively alleviates spasticity, but fails to reverse upstream neural pathway damage, resulting in a “functional ceiling” in motor recovery. Intermittent theta-burst stimulation (iTBS) and functional electrical stimulation (FES) have shown potential for enhancing neuroplasticity; however, their combined use as adjuncts to ITB in SPG11 remains unreported. Case presentation: A 23-year-old female patient with genetically confirmed SPG11 was admitted 2 weeks after ITB pump implantation with severe lower-limb spasticity, an inability to walk independently, and mild anxiety and depression. The patient underwent a 3-month combined intervention comprising iTBS, FES, and conventional rehabilitation, with dynamic interdisciplinary titration of the ITB dosage. Outcomes were assessed using the Modified Ashworth Scale (MAS), Manual Muscle Testing (MMT), the Berg Balance Scale, center of pressure analysis, the Hamilton Anxiety Scale (HAMA), and the Hamilton Depression Scale (HAMD). Outcomes: After 3 months of intervention, the optimal ITB dose was determined to be 62.82 μg/d. The MAS scores of both legs progressively declined, accompanied by increased MMT grades and improved standing balance. The HAMA and HAMD scores were markedly reduced. No adverse events occurred during the treatment. Conclusions: The combination of iTBS and FES as adjuncts to ITB was associated with improvements in motor function, balance, and psychological status in patients with SPG11. Dynamic interdisciplinary titration of the ITB dose may be important for balancing spasticity control and motor learning.